Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study-Reference-Cited by-同舟云学术

Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study

Published:2018-04 Issue:4 Volume:18 Page:410-418
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Beigel John H,Voell Jocelyn,Kumar Parag,Raviprakash Kanakatte,Wu Hua,Jiao Jin-An,Sullivan Eddie,Luke Thomas,Davey Richard T

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference13 articles.

1. Middle East respiratory syndrome;Arabi;N Engl J Med,2017

2. Feasibility of using convalescent plasma immunotherapy for MERS-CoVinfection, Saudi Arabia;Arabi;Emerg Infect Dis,2016

3. The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease;Winkler;Curr Opin Hematol,2015

4. Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study;Beigel;Lancet Respir Med,2017

5. Species-specific chromosome engineering greatly improves fully human polyclonal antibody production profile in cattle;Matsushita;PLoS One,2015

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 and the Interplay With Antibacterial Drug Resistance;Advances in Medical Diagnosis, Treatment, and Care;2024-03-15

2. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Travellers;Emerging and Re-emerging Infections in Travellers;2024

3. Potential role of hyperimmune milk as a source of passive immunotherapy against COVID-19: A review;International Dairy Journal;2023-12

4. Biology and Behavior of Severe Acute Respiratory Syndrome Coronavirus Contagion with Emphasis on Treatment Strategies, Risk Assessment, and Resilience;COVID;2023-08-27

5. Pharmacokinetics of antibodies during pregnancy: General pharmacokinetics and pregnancy related physiological changes (Part 1);International Immunopharmacology;2023-04